Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aspira Women's Health Inc. (AWH)
:AWH
Holding AWH?
Track your performance easily
AWH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.38 - $5.65
Previous CloseN/A
Volume70.14K
Average Volume (3M)85.00K
Market Cap
$9.04M
Enterprise Value$12.49M
Total Cash (Recent Filing)$5.24M
Total Debt (Recent Filing)$1.67M
Price to Earnings (P/E)―
Beta0.60
Next Earnings
Mar 27, 2025EPS Estimate
-0.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.20
Shares Outstanding17,529,793
10 Day Avg. Volume87,062
30 Day Avg. Volume84,999
Standard Deviation0.30
R-Squared0.06
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.96
Price to Cash Flow (P/CF)-0.70
P/FCF Ratio0.00
Enterprise Value/Market Cap1.38
Enterprise Value/Revenue1.38
Enterprise Value/Gross Profit2.37
Enterprise Value/Ebitda-0.80
Forecast
1Y Price Target
$3.00Price Target Upside476.92% Upside
Rating ConsensusHold
Number of Analyst Covering0
Aspira Women's Health News
PremiumCompany Announcements
Aspira Women’s Health CFO Resignation and Leadership Update
PremiumCompany Announcements
Aspira Women’s Health CEO Transition and Leadership Change
Options Prices
Currently, No data available
---
Ownership Overview
18.67% Insiders
1.99% Mutual Funds
<0.01% Other Institutional Investors
77.66% Public Companies and
Individual Investors
AWH FAQ
What was Aspira Women's Health Inc.’s price range in the past 12 months?
Aspira Women's Health Inc. lowest stock price was $0.38 and its highest was $5.65 in the past 12 months.
What is Aspira Women's Health Inc.’s market cap?
Aspira Women's Health Inc.’s market cap is $9.04M.
When is Aspira Women's Health Inc.’s upcoming earnings report date?
Aspira Women's Health Inc.’s upcoming earnings report date is Mar 27, 2025 which is in 67 days.
How were Aspira Women's Health Inc.’s earnings last quarter?
Aspira Women's Health Inc. released its earnings results on Nov 14, 2024. The company reported -$0.28 earnings per share for the quarter, missing the consensus estimate of -$0.258 by -$0.022.
Is Aspira Women's Health Inc. overvalued?
According to Wall Street analysts Aspira Women's Health Inc.’s price is currently Undervalued.
Does Aspira Women's Health Inc. pay dividends?
Aspira Women's Health Inc. does not currently pay dividends.
What is Aspira Women's Health Inc.’s EPS estimate?
Aspira Women's Health Inc.’s EPS estimate is -0.22.
How many shares outstanding does Aspira Women's Health Inc. have?
Aspira Women's Health Inc. has 17,529,793 shares outstanding.
What happened to Aspira Women's Health Inc.’s price movement after its last earnings report?
Aspira Women's Health Inc. reported an EPS of -$0.28 in its last earnings report, missing expectations of -$0.258. Following the earnings report the stock price went down -9.756%.
Which hedge fund is a major shareholder of Aspira Women's Health Inc.?
Currently, no hedge funds are holding shares in AWH
---
Company Description
Aspira Women's Health Inc.
Vermillion, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. The company's bio-analytical solutions helps physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion was founded on December 9, 1993 and is headquartered in Austin, TX.
---
AWH Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant progress in product development and commercial execution, which resulted in increased test volumes and expanded market opportunities. However, challenges remain in terms of operating costs, cash reserves, and achieving broader payer coverage. The sentiment is cautiously optimistic with substantial achievements, yet underlying financial and operational challenges persist.Read More>---
AWH Stock 12 Month Forecast
Average Price Target
$3.00
▲(476.92% Upside)
Technical Analysis
MiMedx Group
―
OncoCyte
―
Accelerate Diagnostics
―
T2 Biosystems
―
VolitionRX
―
Castle Biosciences
―
Best Analysts Covering AWH
1 Year
1 Year Success Rate
0/2 ratings generated profit
1 Year Average Return
-75.60%
reiterated a buy rating 12 months ago
Copying Ben Haynor's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -75.60% per trade.
---